Navigation Links
New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
Date:4/11/2012

FARMINGTON, Conn., April 11, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new biotech and pharmaceutical market research reports from Global Industry Analysts, available immediately, which detail strong forecasts for the chiral technology, laboratory chemical reagents, and electrophoresis equipment and supplies markets coming out of the global economic recession.

Chiral Technology: A Global Strategic Business Report

The global market for chiral technology enabling products is forecast to reach $5.1 billion by the year 2017, according to Global Industry Analysts' (GIA) comprehensive new market research report, Chiral Technology Enabling Products. The rising demand for enantiopure compounds and technological advancements in terms of speed, efficacy, automation, and increased throughput will help fuel demand for chiral technology in the upcoming years, and the extension of patent protection for drugs manufactured from enantiomers will be a key factor driving the growth of chiral technology for pharmaceuticals.

GIA's Chiral Technology: A Global Strategic Business Report provides a comprehensive review of the chiral technology enabling products markets, impact of the global recession on the market, current trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. This report provides annual sales estimates and projections for chiral technology enabling products market for the years 2009 through 2017 for the following geographic markets - US, Japan, Europe, and Rest of World, and by product segments – Chiral Intermediates, Chiral Analytical Products, and Others. Major end-use markets analyzed in the report include Pharmaceuticals and Agrochemicals. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.

An Executive Summary of this research and a free sample of the full report are available at http://www.giiresearch.com/report/go236736-chiral-technology.html

Laboratory Chemical Reagents: A Global Strategic Business Report

GIA projects the global market for laboratory chemical reagents to reach $18 billion by the year 2017, driven by technological advancements that are enhancing scientific community's ability to identify and produce important human therapeutic agents. Emerging applications areas and expanding commercial applications are expected to further fuel growth in the market.

The new laboratory chemical reagents market research from GIA provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) across geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia Pacific, Latin America and Rest of World. Key product segments analyzed include Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression Vectors Cloning & Sequencing, Gene Synthesis, Extraction Kits, PCR Reagents, Enzymes, and Others), Biochemistry (IVD), Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing (Pesticide Residues and Others).

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/go236849-laboratory-chemical-reagents.html

Electrophoresis Equipment and Supplies: A Global Strategic Business Report

The global market for electrophoresis equipment and supplies is forecast to reach US$1.7 billion by the year 2017 according to new research from GIA. Their market research report Electrophoresis Equipment and Supplies: A Global Strategic Business Report offers a comprehensive review of the electrophoresis equipment and supplies markets, and includes a thorough analysis of impact of the recession on the market, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for the Electrophoresis Equipment and Supplies market for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, the Middle East, and Latin America. Key product segments analyzed include Gel Electrophoresis Systems, Capillary Electrophoresis Systems, and Electrophoresis Gels/Reagents. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/go236846-electrophoresis-equipment-supplies.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
3. Biotech firm spun off from Childrens Hospital raises $7 million to advance vascular treatment
4. New project could herald cheaper and more efficient biotechnology
5. Sustainable land use strategies to support bioenergy described in Industrial Biotechnology journal
6. 2012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions
7. BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines
8. Exploiting Trichoderma: From food security to biotechnology
9. Andromeda Biotech: A drug for type 1 diabetes
10. Biotech start-up brings DNA-sequencing to the medical market
11. FDA grants cardiotrophin-1 Orphan Drug status for acute liver failure treatment to Digna Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
Breaking Biology Technology: